HCA Holdings (HCA) Misses Q2 EPS by 6c

Go back to HCA Holdings (HCA) Misses Q2 EPS by 6c

HCA Holdings (HCA) PT Lowered to $92 at Mizuho Securities; Reiterates Buy

July 26, 2017 7:17 AM EDT

Mizuho Securities lowered its price target on HCA Holdings (NYSE: HCA) to $92.00 (from $98.00) while maintaining a Buy rating. Analyst Sheryl Skolnick still believes that HCA can still preserve margin in 2018, can still grow the top line and can generate around 4% EBITDA... More

BofA/Merrill Lynch Downgrades HCA Holdings (HCA) to Neutral

July 26, 2017 6:21 AM EDT

BofA/Merrill Lynch downgraded HCA Holdings (NYSE: HCA) from Buy to Neutral with a price target of $92.00 (from $102.00).

Analyst Kevin Fischbeck says the bull case for the company is a classic "best house on a bad block" noting his concerns with weak volumes,... More